Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With <i>EGFR</i> Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung CancerCaicun Zhou, Pasi A. Jänne, Danny Nguyen et al.|JAMA Oncology|2021Cited by 289
PPD01.02 Repotrectinib in Patients With ROS1 Fusion-Positive (ROS1+) NSCLC: Update From the Pivotal Phase 1/2 TRIDENT-1 TrialAlexander Drilon, Byoung Chul Cho, Ki Hyeong Lee et al.|Journal of Thoracic Oncology|2024Cited by 0